Search results for: Health Data and Statistics
Filter search results
Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions
1 March 2018
OHE Research Paper 18/02: Real World Evidence (RWE) – This paper provides a framework and specific steps to help both manufacturers and payers meet the challenge of developing observational RWE…
Margaret Kyle
3 February 2023
…published in various journals of economics, strategy, health policy and competition policy, including the Quarterly Journal of Economics, RAND Journal of Economics, Review of Economics and Statistics, Journal of Law…
Multiple Sclerosis
10 January 1987
…a thousand lives a year in England and Wales and is responsible for an estimated 92,000 bed-days in NHS hospitals in England. In the primary care sector, general practitioners experience…
2024 Innovation Policy Prize Award Ceremony
28 January 2025, 6:00pm
…chosen to focus the prize on the nexus between climate change and health. Our expert judging panel will discuss the challenges we are facing and the broader range of ideas…
Economic Evidence and NHS Reforms in England
19 January 2011
…the NHS’, announced major reforms to health care in England. In December, OHE and the Centre for Health Economics (CHE) of the University of York held an interactive workshop for…
Andrew Davies
19 March 2024
Andrew is the Digital Health Lead and Executive Director of The Association of British HealthTech Industries (ABHI). As well as this, he is the Non-Executive Director of Biostealth and York…
Martina Garau
22 May 2014
…expanding the evidence used in healthcare resource allocation decisions and shaping the debate around critical health policy issues. Her areas of expertise include value assessments in high- and middle- income…
Lotte Steuten
8 January 2019
…current research interests include applied health economics, health policy and market access. She specializes in quantitative methods for estimating and comparing the expected health and economic benefits of new interventions…
OHE responds to the Trump administration’s Executive Order on Drug Prices
14 May 2025
…international value assessment from countries with very different health care systems and opportunity costs. Reference pricing also overlooks the issue of confidential price negotiations between the pharmaceutical industry and individual…